Talk:Antibody-vaccine engineered construct

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Science Low‑importance

	Science portal This article is within the scope of WikiProject Science, a collaborative effort to improve the coverage of Science on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.ScienceWikipedia:WikiProject ScienceTemplate:WikiProject Sciencescience articles
Low	This article has been rated as Low-importance on the project's importance scale.

This article references a source that one of the article's contributors wrote or published. Citing oneself is allowed on Wikipedia, but may represent a conflict of interest. Contributors should be careful not to place undue weight on their own work, and are discouraged from excessive self-citation. Guidelines relevant to this situation include Wikipedia:Conflict of interest, Wikipedia:Neutral point of view and WP:SELFPUBLISHED.

Marek Malecki MD (talk) 04:39, 1 May 2017 (UTC)[reply]

^ Malecki M, Sabo C, Foorohar A, Tombokan X. Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B. Clinical and Translational Medicine. 2016;5:32. doi:10.1186/s40169-016-0111-8. PMC 4990520.